Aantiviral Favipiravir

Glenmark Begins Phase 3 of Clinical Trials on Aantiviral Favipiravir for COVID-19 Patients in India

"Clinical trials have commenced and over 10 leading government and private hospitals in India are being enrolled for the study. Glenmark estimates study completion by July or August," it said in a statement.